Best Value Stocks to Buy for September 23rd

Zacks highlighted Lifetime Brands, MediaAlpha and Horace Mann Educators as Zacks Rank #1 value stocks. Current-year consensus EPS estimates rose 184.9% for Lifetime Brands, nearly 32% for MediaAlpha and 6.2% for Horace Mann over the past 60 days. The article is analyst-driven stock-selection commentary and is unlikely to have material broad market impact.

Analysis

This is low-information, promotional research rather than an independently validated fundamental catalyst; no broad rerating should be inferred from estimate revisions alone. The relevant mechanism is whether revisions reflect durable revenue/margin improvement versus a reduced prior base, non-operating items, or a single-quarter underwriting/marketing swing. Liquidity is the primary near-term constraint: LCUT and MAX can move sharply on retail flows, but those gains are vulnerable to reversal without confirming earnings guidance.

MAX is the only name with a potentially scalable operating catalyst: stronger carrier demand and favorable insurance-shopping economics can produce high incremental contribution margins because its marketplace has largely variable acquisition costs. The key 1-3 month validation is whether management sustains revenue growth and EBITDA/adjusted-EBITDA guidance while customer concentration and traffic-acquisition costs remain controlled; a guide-down in carrier budgets would compress its growth multiple quickly. HMN's earnings sensitivity is more likely tied to loss-ratio and investment-income normalization, making it a lower-beta defensive expression rather than a revision-momentum trade.

LCUT's unusually large revision percentage is not, by itself, evidence of a recovery: small-cap consumer durables remain exposed to retailer inventory discipline, promotional intensity, freight/input costs, and a weak housing/discretionary backdrop. A modest sales miss can erase the implied earnings leverage given fixed-cost absorption and leverage risk. Contrarian read: consensus screens systematically reward the direction of estimates, while the market should care more about estimate quality and free-cash-flow conversion; absent disclosed drivers, this signal is underwriteable only after the next report.

No read-through exists for QBTS; its inclusion in the structured ticker set is unsupported by the underlying item. Avoid treating this as a quantum-computing catalyst.

Key Decisions for Investors

• Watch, do not initiate LCUT on the revision signal. Reassess at the next earnings release only if management confirms full-year guidance, retailer replenishment, and positive operating cash flow; invalidate any bullish setup on renewed gross-margin pressure or inventory build. Given small-cap liquidity, size any eventual position at less than half a normal risk allocation.
• Maintain a 1-3 month MAX watch-long bias rather than chase a screen-driven move. Enter only after guidance confirms carrier-spend durability and stable customer-acquisition economics; use a roughly 8-10% stop or exit on a revenue/EBITDA guide reduction, targeting 15-20% upside if estimates continue to rise.
• For defensive financials exposure over 3-6 months, prefer HMN only as part of a pair: long HMN / short KIE or a higher-beta personal-lines insurer basket. The thesis requires improving underwriting results without reserve deterioration; exit if the combined ratio worsens or catastrophe losses force a reserve/guidance revision.
• Exclude QBTS from any action list associated with this item; require a company-specific contract, funding, or commercialization catalyst before assigning it portfolio risk.